The groundbreaking therapy of tirzepatide peptide represents a major development in the handling of type 2 diabetes. Different to existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide804993.isblog.net/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-59391732